open access

Vol 8, No 2 (2012)
Case report
Published online: 2012-06-27
Get Citation

Cetuximab as salvage therapy in 82 year old women with metastatic colon cancer.

Krzysztof Krzemieniecki
Onkol. Prak. Klin 2012;8(2):65-66.

open access

Vol 8, No 2 (2012)
CASE REPORT
Published online: 2012-06-27

Abstract

Anticancer treatment offered to elderly requests basic knowledge on geriatric problems and understanding the limits related to reduced functional reserves. Cetuximab was prescribed as the rescue monotherapy to 82 years old women with metastatic colon cancer following failure of systemic treatment. The decrease in bothersome disease symptoms and temporary remission of metastatic lesions revealed in the imaging assessment were observed during treatment. Patient survived additional 10 months. Treatment was  well tolerated and toxicity was easy manageable. Monotherapy with cetuximab can be a valuable palliative option in the adequately selected patients.

Abstract

Anticancer treatment offered to elderly requests basic knowledge on geriatric problems and understanding the limits related to reduced functional reserves. Cetuximab was prescribed as the rescue monotherapy to 82 years old women with metastatic colon cancer following failure of systemic treatment. The decrease in bothersome disease symptoms and temporary remission of metastatic lesions revealed in the imaging assessment were observed during treatment. Patient survived additional 10 months. Treatment was  well tolerated and toxicity was easy manageable. Monotherapy with cetuximab can be a valuable palliative option in the adequately selected patients.

Get Citation

Keywords

przerzutowy rak jelita grubego, chorzy w podeszłym wieku, cetuksymab

About this article
Title

Cetuximab as salvage therapy in 82 year old women with metastatic colon cancer.

Journal

Oncology in Clinical Practice

Issue

Vol 8, No 2 (2012)

Article type

Case report

Pages

65-66

Published online

2012-06-27

Bibliographic record

Onkol. Prak. Klin 2012;8(2):65-66.

Keywords

przerzutowy rak jelita grubego
chorzy w podeszłym wieku
cetuksymab

Authors

Krzysztof Krzemieniecki

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl